CClinicalTrials.gg
CompletedNCT03085537PRE-HVNIUpdated Mar 9, 2022

Effectiveness Monitoring of Home Non-invasive Mechanical Ventilation by Digital Diagnosis Platform

An observational study in Neuromuscular Diseases, Obesity Hypoventilation Syndrome and Lung Disease, Restrictive, sponsored by Corporacion Parc Tauli. Completed at 3 sites in Spain. Open to participants aged 18 Years to 85 Years. Per ClinicalTrials.gov, last updated 2022-03-09.

Sponsored by Corporacion Parc Tauli · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
40
Ages
18 Years to 85 Years
Sex
All
01

Study summary

The main objective will be to determine the effectiveness of home non-invasive ventilation by flow-time and time-pressure curves analysis in a cohort of patients with this treatment by digital diagnosis platform.

Read the detailed description

A multicenter study with observational prospective design will be implemented on 3 spanish hospitals in Barcelona. Inclusion criteria will be equivalent sample size of patients with restrictive lung disease, neuromuscular pathology and hypoventilation-obesity.

Digital diagnosis platform will be used to incorporate and unify signals of different medical devices: a pneumotachograph on branch ventilator that captures pressure and flow-time signals, inductance plethysmography used to like a patient effort sensor and portable pulse oximeter recordings. Nocturnal polygraphic or polysomnographic tracings performed and recorded on sites will be processed systematically by main asynchronies diagnosis algorithms between patient and ventilator. These algorithms providing global and fractionated asynchronies count based on time, leaks or saturation criteria which will be used to compared effective ventilation phases and phases with nocturnal desaturations. Therefore, prevalence and asynchronies model on home NIV can be determine establishing the correlation between desaturation phases and respiratory events and identifying minimum tolerable leak level to keep adequate ventilation.

02

Conditions studied

  • Neuromuscular Diseases
  • Obesity Hypoventilation Syndrome
  • Lung Disease, Restrictive

Keywords

  • home monitoring
  • Non-invasive mechanical ventilation
03

In context

Lung Diseases

3,303 studies on the registry are indexed under Lung Diseases; 355 are open to participants now.

This study's enrollment of 40 is below the median of 157 across 929 observational studies indexed under Lung Diseases.

Browse Lung Diseases studies →

Lead sponsor

Corporacion Parc Tauli is the lead sponsor of 163 studies on the registry; 25 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients affected by restrictive lung disease, neuromuscular disorders or hypoventilation-obesity with home non-invasive mechanical ventilation.

Inclusion criteria

  • Home non-invasive mechanical ventilation and clinical stability at least of 6 months ( no acute episode with admission on 2 months before)
  • Mean Ventilator compliance > 4 h/ per night on screening visit
  • Signed informed consent form previously

Exclusion criteria

Exclusion Criteria:

  • Ventilation with oxygen join system.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
40 participants (actual)
Target follow-up
1 Day
Patient registry
Yes
06

What researchers measure

Primary outcomes

  1. Asynchronies Index

    Number of respiratory events registered automatically by digital diagnosis platform

    Time frame: One week after screening visit if the subject comply inclusion criteria. Asynchronies analysis will be performed once (cross-sectional design) by nocturnal polygraphy on site during one night

Secondary outcomes

  1. Leaks

    Presence or not of intencionals and unintencionals leaks recorded

    Time frame: One week after screening visit if the subject comply inclusion criteria. leaks analysis will be performed once (cross-sectional design) by nocturnal polygraphy on site during one night

  2. Oxygen saturation

    Measure by pulsy oxymetry (%)

    Time frame: One week after screening visit if the subject comply inclusion criteria. Oxygen saturation analysis will be performed once by nocturnal polygraphy once (cross-sectional design) on site during one night

  3. Demographics parameters- age

    age in years

    Time frame: screening visit

  4. Demographics parameters- sex

    sex: man or woman

    Time frame: screening visit

  5. Pathology indication

    asociated with starting mechanical ventilation

    Time frame: screening visit

  6. PaCO2

    PaCo2 measured by blood gas test (mmHg) \< 45

    Time frame: screening visit

  7. Pittsburgh Sleep Quality Index. (PSQI)

    questionaire of sleep quality with ventilation.

    Time frame: screening visit

  8. Mode Ventilator

    pressure or volume controlled modes. select the option at ventilator setings

    Time frame: recorded date on screening visit

  9. Interfaces

    kind of mask using between the patient and ventilator. Total face mask, nasal mask, oro-nasal mask depend of patient characteristics

    Time frame: recorded date on screening visit

  10. Tube

    Kind of tuve, simple or doublé between patient and ventilator

    Time frame: recorded date on screening visit

  11. Antyrebreathing system

    Kind of system that avoid rebreathing CO2: acitve valve, leak controlled mask, leak controlled tube or double circuit

    Time frame: recorded date on screening visit

  12. Compliance ventilator

    complying or not mínimum hours to recruiting (4h)

    Time frame: recorded date on screening visit

07

Study locations

3 sites
  • Hospital universitari de Bellvitge
    Hospitalet de Llobregat, Barcelona 08907, Spain
  • Corporación Sanitaria Parc Tauli
    Sabadell, Barcelona 08208, Spain
  • Hospital Vall d´Hebron
    Barcelona, 08035, Spain
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 9, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03085537
Lead sponsor
Corporacion Parc Tauli
Collaborators
Sociedad Española de Neumología y Cirugía Torácica
Responsible party
Manel Lujan-Torne (Lung specialist doctor, Corporacion Parc Tauli) — Principal investigator
First posted
Mar 21, 2017
Start date
Oct 1, 2016
Primary completion
Sep 30, 2018
Completion
Oct 30, 2021
Last update
Mar 9, 2022

Study contacts

Manel Lujan
principal investigator · Corporation PT
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion